etpm Volume: 01, Issue: 01 Year: 2024

Editors Overview

etpm maintains an Editorial Board of practicing researchers from around the world, to ensure manuscripts are handled by editors who are experts in the field of study.

5

Regular Issue  Subscription Review Article Published on :- Mar 26, 2024

The Impact of Telemedicine on Healthcare Delivery: A Comprehensive Review

By  

 

Shweta Tomar,
Abstract : Thanks to advancements in telecommunications technology, telemedicine has become a disruptive force in the delivery of healthcare, bridging read more

[This section belongs to Emerging Trends in Personalized Medicines (etpm)]

 

 

1-4
Regular Issue  Subscription Review Article Published on :- Mar 10, 2024

DMARDs, Biologic Agents and Novel Experimental Strategies in The Treatment of Rheumatoid Arthritis

By  

 

Sagrika Kukade, Shilpa S. Borkar, Pankaj Dhapake, Jagdish R. Baheti,
Abstract : Rheumatoid arthritis (RA) is an inflammatory and autoimmune illness that causes tremendous pain and swelling in the body’s affected regions. As per read more

[This section belongs to Emerging Trends in Personalized Medicines (etpm)]

 

 

14-24
Regular Issue  Subscription Original Research Published on :- Mar 20, 2024

Development and Validation of a Robust RP-HPLC Method for Rufinamide Quantification in Pharmaceutical Dosage Forms

By  

 

Thonta Harini Kumari, Mr.Shaik Ejas,
Abstract : The creation and validation of a simple, precise, and targeted reverse phase high-performance liquid chromatographic (RP-HPLC) approach allowed for read more

[This section belongs to Emerging Trends in Personalized Medicines (etpm)]

 

 

25-32
Regular Issue  Subscription Original Research Published on :- Mar 28, 2024

Role of W.A.R. Score in Predicting Wound Infection

By  

 

Ravi Kumar Chittoria, Vaibhav Shukla, Jacob Antony Chakiath, Amrutha J S,
Abstract : In clinical practice, chronic wounds are a major difficulty that are frequently made worse by the infection risk. However, the lack of precise read more

[This section belongs to Emerging Trends in Personalized Medicines (etpm)]

 

 

33-38
Regular Issue  Subscription Original Research Published on :- Mar 20, 2024

Lamivudine And Dolutegravir Simultaneous Dosage Forms Determined and Validated Using The RP-UPLC Method

By  

 

Sadaf Sultana, Mr.Shaik Ejas,
Abstract : RP-UPLC has been used to produce a straightforward, precise, and accurate approach for the simultaneous estimation of dolutegravir and lamivudine in a read more

[This section belongs to Emerging Trends in Personalized Medicines (etpm)]

 

 

5-13